Zobrazeno 1 - 8
of 8
pro vyhledávání: '"E. Gaydukova"'
Publikováno v:
Annals of the Rheumatic Diseases. 81:968.1-968
BackgroundDecrease of COVID-19-associated morbidity and mortality among patients with rheumatic diseases (RD) is one of the main goals of current rheumatology. Vaccination may be one way to limit the incidence of COVID-19 in population of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaa6748d9567a0624633f25b34671fd1
https://doi.org/10.1136/annrheumdis-2022-eular.4250
https://doi.org/10.1136/annrheumdis-2022-eular.4250
Autor:
A V Nezhdanova, S E Gaydukova, I V Yakovleva, A A Davlekamova, A O Zakurin, A M Kamionskaya, B Ts Shagdarova, T A Timofeeva
Publikováno v:
IOP Conference Series: Earth and Environmental Science. 839:042027
The work studied the effect of low molecular weight chitosan hydrolyzate on the growth and development of phytopathogens Botrytis cinerea, Fusarium solani, Alternaria solani. Chitosan hydrolyzate, when added to potato-glucose agar, inhibits the growt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a5e22de03426230c605c544ad59b501
https://doi.org/10.1088/1755-1315/839/4/042027
https://doi.org/10.1088/1755-1315/839/4/042027
Autor:
Alexander Lila, Nasonov El, E. Gaydukova, L. Solodovnikova, E. Kryukova, N. Lapkina, V. Mazurov, O. Semagina, Diana Abdulganieva, S A Lapshina, Inna Gaydukova, D. Kretchikova, I. Vinogradova, L. Myasoutova, O. Epifanova
Publikováno v:
Annals of the Rheumatic Diseases. 79:1470-1471
Background:Currently it is unclear whether combination of tofacitinib (tofa) with methotrexate (Mtx) more effective and safe than tofa in monotherapy.Objectives:To compare efficacy and safety of tofacitinib monotherapy with combination of tofa and mt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13ee54e17f37759a9fb86c0bc5f9eb50
https://doi.org/10.1136/annrheumdis-2020-eular.4773
https://doi.org/10.1136/annrheumdis-2020-eular.4773
Autor:
Alexander Lila, I. M. Marusenko, I. Grabovetskaya, A. Baranov, E. Gaydukova, Nasonov El, V. Sorotskaya, V. Mazurov, T. Salnikova, Galina Lukina, D. Chakieva, Inna Gaydukova, A. R. Babaeva, E. Kalinina, R. Samigullina
Publikováno v:
Annals of the Rheumatic Diseases. 79:1469-1470
Background:Tofacitinib is an oral Janus Kinase inhibitor for the treatment of rheumatoid arthritis (RA). The survival of remission or low disease activity (LDA) in RA patients, treated with tofacitinib remain unknown.Objectives:To evaluate the surviv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::941192d587e76a993966b52691b5e1ae
https://doi.org/10.1136/annrheumdis-2020-eular.4710
https://doi.org/10.1136/annrheumdis-2020-eular.4710
Autor:
Inna Gaydukova, E. Koltsova, E. Shmidt, O. Fomina, V. Poncratov, E. Zhilyaev, E. Gaydukova, Alexander Lila, V. Mazurov, O. Anoshenkova, N. Yudina, A. Vasilenko, Nasonov El, L. Knyazeva, Irina Bondareva, E. Vasilenko, A. Baranov, Galina Lukina
Publikováno v:
Annals of the Rheumatic Diseases. 79:1008.1-1009
Background:Tofacitinib is an oral Janus Kinase inhibitor for the treatment of rheumatoid arthritis (RA).Objectives:To evaluate the three-year effectiveness of tofacitinib in RA conventional synthetic (cs) DMARDs non-responders.Methods:Data from 374 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::babe0792e88b4486712cea4a788e0611
https://doi.org/10.1136/annrheumdis-2020-eular.4664
https://doi.org/10.1136/annrheumdis-2020-eular.4664
Publikováno v:
Annals of the Rheumatic Diseases. 79:1638.1-1639
Background:Due to current data mean diagnostics delay in axial spondyloarthritis (axSpA) is 7.4 ± 8.4 years (mean ± SD) [1]. However, development of specific and high sensitive criteria of axSpA do not improve the situation because one of the main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::478d9cf099c18a35bb55dbe81b5915d2
https://doi.org/10.1136/annrheumdis-2020-eular.3811
https://doi.org/10.1136/annrheumdis-2020-eular.3811
Publikováno v:
Экологическая генетика, Vol 6, Iss 4, Pp 20-28 (2008)
Regeneration parameters were optimized and effective selection conditions were sorted out. Transgenic plants of Lemna minor were obtained and their status was confirmed by molecular analysis. Optimized methodology can be used for obtaining transgenic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b40068469f92a7342ecd4b2f1d27976
https://doi.org/10.17816/ecogen6420-28
https://doi.org/10.17816/ecogen6420-28
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.